192P Real-world treatment patterns in stage III and IV melanoma patients treated with anti-PD-1 as adjuvant or advanced therapy

Real-world studies are needed to understand treatment patterns for patients who initiate anti-PD-1 therapy for stage III and IV melanoma, to identify unmet medical needs and improve patient management.

Authors

Institutions

Publication Details

Journal
Immuno-Oncology Technology
Published
2025-12-01
DOI
https://doi.org/10.1016/j.iotech.2025.101275
Primary Topic
Cutaneous Melanoma Detection and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

192P Real-world treatment patterns in stage III and IV melanoma patients treated with anti-PD-1 as adjuvant or advanced therapy

Sayka Alam, R. Jiang, C. Gebhardt, K. Gandhi et al.
Immuno-Oncology Technology
Cutaneous Melanoma Detection and Management
article

192P Real-world treatment patterns in stage III and IV melanoma patients treated with anti-PD-1 as adjuvant or advanced therapy

Sayka Alam, R. Jiang, C. Gebhardt, K. Gandhi, T. Lesimple, S. Danson, J. Charles, P. Saiag, M. Heppt, B. O'Carrigan, A. Rodriguez Garcia, N. Qizilbash, D. Debus, J.C. Hassel, X. Tan, R. Frazer, S. Dalle, I. Shui, C. Robert, C. Krepler
article en

Abstract

Real-world studies are needed to understand treatment patterns for patients who initiate anti-PD-1 therapy for stage III and IV melanoma, to identify unmet medical needs and improve patient management.

Immuno-Oncology TechnologyVol. 28
Merck & Co., Inc., Rahway, NJ, USA (United States) (US), Universität Hamburg (DE), Friedrich-Alexander-Universität Erlangen-Nürnberg (DE), Saint Louis University (ES), Heidelberg University (DE), Velindre NHS Trust (GB), Centre Hospitalier Universitaire de Grenoble (FR), Institut Gustave Roussy (FR), University Hospital Heidelberg (DE), Weston Park Cancer Centre (GB), Cancer Research UK Cambridge Center (GB), Assistance Publique – Hôpitaux de Paris (FR), Centro Nacional de Epidemiología (ES), University Medical Center Hamburg-Eppendorf (DE), Mount Vernon Cancer Centre (GB), Centre Eugène Marquis (FR), Hôpital Lyon Sud (FR), Klinikum Arnsberg (DE), Hôpital Ambroise-Paré (FR), Velindre Cancer Centre (GB), Addenbrooke's Hospital (GB), Chirurgische Universitätsklinik Heidelberg (DE), Université Grenoble Alpes (FR)
Openalex Percentile: Top 31%
Cutaneous Melanoma Detection and Management
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

192P Real-world treatment patterns in stage III and IV melanoma patients treated with anti-PD-1 as adjuvant or advanced therapy — Sayka Alam, R. Jiang, et al. · Immuno-Oncology Technology (2025) | TGRS Research Map | TGRS